|
End-of-day quote
Korea S.E.
14/08/2026
|
5-day change | 1st Jan Change | ||
| 2,01,000.00 KRW | -0.50% |
|
+0.85% | +16.60% |
| 04/08 | Celltrion Files Phase 3 Trial Amendment for CT-P44 Biosimilar for Myeloma | MT |
| 24/07 | Celltrion Submits EMA Marketing Authorization Application for Cosentyx Biosimilar CT-P55 | MT |
Chart: Technical Analysis
Stock exchange
Korea S.E.
A068270 2,01,000.00 ₩
-0.50%
6.86TCr
₩
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Korea S.E.
| A068270 | 2,01,000.00KRW | -0.50% | 6.86TCr ₩ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 2,10,500 | 2,36,667 | 2,30,476 |
| Spread/Res. | -4.51% | -15.07% | -12.79% |
| Spread/Supp. | +5.79% | +26.10% | +23.57% |
| Support | 1,90,000 | 1,59,400 | 1,62,667 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- A068270 Stock
- Charts Celltrion, Inc.
Select your edition
All financial news and data tailored to specific country editions
